volume 36 issue 7 pages 1703-1719

The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms

E Solary 2
Oussama Abla 3
Yassmine M N Akkari 4
Rita Alaggio 5
Rafael Bejar 7
Emilio Berti 8
L. Busque 9
John K.C. Chan 10
Wei-Na Chen 11
Xueyan Chen 12
Wee Joo Chng 13
John Choi 14
Isabel Colmenero 15
Sarah E Coupland 16
Nicholas R Cross 17
Daphne de Jong 18
M. Tarek Elghetany 19
Emiko Takahashi 20
J. Emile 21
Judith Ferry 22
Linda Fogelstrand 23
Michaela Fontenay 24
Ulrich Germing 25
Sumeet Gujral 26
Torsten Haferlach 27
Claire Harrison 28
Jennelle C. Hodge 29
Shimin Hu 1
Joop H. Jansen 30
C Kratz 32
Xiao-Qiu Li 33
Megan S. Lim 34
Keith Loeb 35
Sanam Loghavi 1
Andrea Marcogliese 19
Soheil Meshinchi 36
Phillip Michaels 37
Kikkeri N. Naresh 35
Yasodha Natkunam 38
Reza Nejati 39
GERMAN OTT 40
E. Padron 41
Keyur P Patel 1
Nikhil Patkar 42
Jennifer Picarsic 43
Irene Roberts 45
A. Schuh 46
William Sewell 47
Reiner Siebert 48
Prashant Tembhare 42
Jeffrey W. Tyner 49
S. Verstovsek 31
Wei Wang 1
Brent Wood 50
Wen-Bin Xiao 51
Cecilia C. S. Yeung 35
10
 
Department of Pathology, Queen Elizabeth Hospital, Kowloon, Hong Kong
27
 
MLL Munich Leukemia Laboratory, Munich, Germany
28
 
Department of Haematology, Guys and St Thomas’ NHS Foundation Trust, London, UK
Publication typeJournal Article
Publication date2022-06-22
scimago Q1
wos Q1
SJR3.458
CiteScore18.5
Impact factor13.4
ISSN08876924, 14765551
Cancer Research
Oncology
Hematology
Abstract
The upcoming 5th edition of the World Health Organization (WHO) Classification of Haematolymphoid Tumours is part of an effort to hierarchically catalogue human cancers arising in various organ systems within a single relational database. This paper summarizes the new WHO classification scheme for myeloid and histiocytic/dendritic neoplasms and provides an overview of the principles and rationale underpinning changes from the prior edition. The definition and diagnosis of disease types continues to be based on multiple clinicopathologic parameters, but with refinement of diagnostic criteria and emphasis on therapeutically and/or prognostically actionable biomarkers. While a genetic basis for defining diseases is sought where possible, the classification strives to keep practical worldwide applicability in perspective. The result is an enhanced, contemporary, evidence-based classification of myeloid and histiocytic/dendritic neoplasms, rooted in molecular biology and an organizational structure that permits future scalability as new discoveries continue to inexorably inform future editions.
Found 
Found 

Top-30

Journals

20
40
60
80
100
120
140
Leukemia
121 publications, 4.12%
Cancers
110 publications, 3.74%
American Journal of Hematology
102 publications, 3.47%
British Journal of Haematology
89 publications, 3.03%
Annals of Hematology
74 publications, 2.52%
Blood
69 publications, 2.35%
Frontiers in Oncology
62 publications, 2.11%
International Journal of Molecular Sciences
62 publications, 2.11%
Blood advances
62 publications, 2.11%
Leukemia and Lymphoma
58 publications, 1.97%
International Journal of Laboratory Hematology
45 publications, 1.53%
Leukemia Research
43 publications, 1.46%
Blood Cancer Journal
41 publications, 1.39%
Cureus
37 publications, 1.26%
HemaSphere
32 publications, 1.09%
Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program
32 publications, 1.09%
Clinical Lymphoma, Myeloma and Leukemia
31 publications, 1.05%
eJHaem
30 publications, 1.02%
International Journal of Hematology
26 publications, 0.88%
Leukemia Research Reports
24 publications, 0.82%
Journal of Clinical Medicine
24 publications, 0.82%
European Journal of Haematology
23 publications, 0.78%
Blood Reviews
20 publications, 0.68%
Frontiers in Immunology
19 publications, 0.65%
Biomedicines
18 publications, 0.61%
Journal of Hematopathology
17 publications, 0.58%
Bone Marrow Transplantation
17 publications, 0.58%
Scientific Reports
17 publications, 0.58%
Hematology
17 publications, 0.58%
20
40
60
80
100
120
140

Publishers

100
200
300
400
500
600
700
Springer Nature
675 publications, 22.96%
Elsevier
525 publications, 17.86%
Wiley
478 publications, 16.26%
MDPI
316 publications, 10.75%
American Society of Hematology
167 publications, 5.68%
Taylor & Francis
130 publications, 4.42%
Frontiers Media S.A.
116 publications, 3.95%
Ovid Technologies (Wolters Kluwer Health)
76 publications, 2.59%
Cold Spring Harbor Laboratory
62 publications, 2.11%
Oxford University Press
32 publications, 1.09%
American Society of Clinical Oncology (ASCO)
27 publications, 0.92%
BMJ
23 publications, 0.78%
SAGE
19 publications, 0.65%
American Association for Cancer Research (AACR)
18 publications, 0.61%
S. Karger AG
14 publications, 0.48%
Walter de Gruyter
13 publications, 0.44%
Research Square Platform LLC
13 publications, 0.44%
Hindawi Limited
12 publications, 0.41%
Spandidos Publications
12 publications, 0.41%
Georg Thieme Verlag KG
11 publications, 0.37%
American Medical Association (AMA)
11 publications, 0.37%
Publishing House ABV Press
11 publications, 0.37%
Fund Doctors, Innovations, Science for Children
7 publications, 0.24%
Baishideng Publishing Group
7 publications, 0.24%
Medknow
6 publications, 0.2%
Remedium, Ltd.
6 publications, 0.2%
Cambridge University Press
5 publications, 0.17%
PAGEPress Publications
5 publications, 0.17%
100
200
300
400
500
600
700
  • We do not take into account publications without a DOI.
  • Statistics recalculated weekly.

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
2.9k
Share
Cite this
GOST |
Cite this
GOST Copy
Khoury J. et al. The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms // Leukemia. 2022. Vol. 36. No. 7. pp. 1703-1719.
GOST all authors (up to 50) Copy
Khoury J. et al. The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms // Leukemia. 2022. Vol. 36. No. 7. pp. 1703-1719.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.1038/s41375-022-01613-1
UR - https://doi.org/10.1038/s41375-022-01613-1
TI - The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms
T2 - Leukemia
AU - Khoury, Joseph
AU - Solary, E
AU - Abla, Oussama
AU - Akkari, Yassmine M N
AU - Alaggio, Rita
AU - Apperley, Jane
AU - Bejar, Rafael
AU - Berti, Emilio
AU - Busque, L.
AU - Chan, John K.C.
AU - Chen, Wei-Na
AU - Chen, Xueyan
AU - Chng, Wee Joo
AU - Choi, John
AU - Colmenero, Isabel
AU - Coupland, Sarah E
AU - Cross, Nicholas R
AU - de Jong, Daphne
AU - Elghetany, M. Tarek
AU - Takahashi, Emiko
AU - Emile, J.
AU - Ferry, Judith
AU - Fogelstrand, Linda
AU - Fontenay, Michaela
AU - Germing, Ulrich
AU - Gujral, Sumeet
AU - Haferlach, Torsten
AU - Harrison, Claire
AU - Hodge, Jennelle C.
AU - Hu, Shimin
AU - Jansen, Joop H.
AU - Kanagal-shamanna, R.
AU - KANTARJIAN, Hagop M.
AU - Kratz, C
AU - Li, Xiao-Qiu
AU - Lim, Megan S.
AU - Loeb, Keith
AU - Loghavi, Sanam
AU - Marcogliese, Andrea
AU - Meshinchi, Soheil
AU - Michaels, Phillip
AU - Naresh, Kikkeri N.
AU - Natkunam, Yasodha
AU - Nejati, Reza
AU - OTT, GERMAN
AU - Padron, E.
AU - Patel, Keyur P
AU - Patkar, Nikhil
AU - Picarsic, Jennifer
AU - Platzbecker, Uwe
AU - Roberts, Irene
AU - Schuh, A.
AU - Sewell, William
AU - Siebert, Reiner
AU - Tembhare, Prashant
AU - Tyner, Jeffrey W.
AU - Verstovsek, S.
AU - Wang, Wei
AU - Wood, Brent
AU - Xiao, Wen-Bin
AU - Yeung, Cecilia C. S.
AU - Hochhaus, Andreas
PY - 2022
DA - 2022/06/22
PB - Springer Nature
SP - 1703-1719
IS - 7
VL - 36
PMID - 35732831
SN - 0887-6924
SN - 1476-5551
ER -
BibTex |
Cite this
BibTex (up to 50 authors) Copy
@article{2022_Khoury,
author = {Joseph Khoury and E Solary and Oussama Abla and Yassmine M N Akkari and Rita Alaggio and Jane Apperley and Rafael Bejar and Emilio Berti and L. Busque and John K.C. Chan and Wei-Na Chen and Xueyan Chen and Wee Joo Chng and John Choi and Isabel Colmenero and Sarah E Coupland and Nicholas R Cross and Daphne de Jong and M. Tarek Elghetany and Emiko Takahashi and J. Emile and Judith Ferry and Linda Fogelstrand and Michaela Fontenay and Ulrich Germing and Sumeet Gujral and Torsten Haferlach and Claire Harrison and Jennelle C. Hodge and Shimin Hu and Joop H. Jansen and R. Kanagal-shamanna and Hagop M. KANTARJIAN and C Kratz and Xiao-Qiu Li and Megan S. Lim and Keith Loeb and Sanam Loghavi and Andrea Marcogliese and Soheil Meshinchi and Phillip Michaels and Kikkeri N. Naresh and Yasodha Natkunam and Reza Nejati and GERMAN OTT and E. Padron and Keyur P Patel and Nikhil Patkar and Jennifer Picarsic and Uwe Platzbecker and others},
title = {The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms},
journal = {Leukemia},
year = {2022},
volume = {36},
publisher = {Springer Nature},
month = {jun},
url = {https://doi.org/10.1038/s41375-022-01613-1},
number = {7},
pages = {1703--1719},
doi = {10.1038/s41375-022-01613-1}
}
MLA
Cite this
MLA Copy
Khoury, Joseph, et al. “The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms.” Leukemia, vol. 36, no. 7, Jun. 2022, pp. 1703-1719. https://doi.org/10.1038/s41375-022-01613-1.